AZD3480
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for AZD3480, covering 2008-09-25 to 2015-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) [Phase 2]